Research & Development

Boosting Intracerebral Hemorrhage Research Through Better Diagnosis
Research & Development Boosting Intracerebral Hemorrhage Research Through Better Diagnosis

Intracerebral hemorrhage (ICH) stands as one of the most challenging and under-investigated types of stroke, demanding urgent attention to improve patient outcomes and advance clinical practices. Unlike ischemic strokes, which have been extensively researched and are widely recognized for their

Can Microbiome Science Revolutionize Everyday Patient Care?
Research & Development Can Microbiome Science Revolutionize Everyday Patient Care?

In an era where personalized medicine is increasingly becoming the norm, microbiome science is emerging as a pivotal player in reshaping patient care. Understanding the intricate relationship between human health and the billions of microbes that inhabit our bodies presents a unique opportunity. By

New Enzyme Target Offers Hope for Childhood Cancer Treatment
Research & Development New Enzyme Target Offers Hope for Childhood Cancer Treatment

Ivan Kairatov is a highly respected biopharma expert who has made significant contributions to the understanding and innovation in cancer research. With a focus on neuroblastoma, a particularly aggressive childhood cancer, his work is paving the way for new treatment strategies. In this interview,

High Reliability Principles to Transform Clinical Trial Enrollment
Research & Development High Reliability Principles to Transform Clinical Trial Enrollment

In the fast-paced world of clinical trials, patient enrollment remains a significant bottleneck, with approximately 80% of trials failing to meet their enrollment goals. This issue not only hampers the development and delivery of new therapeutic solutions but also inflates operational costs

Model Advances Drug Discovery for Ultra-Rare Genetic Disorder
Research & Development Model Advances Drug Discovery for Ultra-Rare Genetic Disorder

In a monumental stride toward understanding and addressing ultra-rare genetic disorders, a research team at Tel Aviv University's Gray Faculty of Medical and Health Sciences has pioneered a groundbreaking model. This endeavor focuses on replicating a perilous condition tied to a mutation in the

Can Immunotherapy Revolutionize Stage 3 Colon Cancer Treatment?
Research & Development Can Immunotherapy Revolutionize Stage 3 Colon Cancer Treatment?

A critical patient is confronted with unsettling news: her colon cancer has returned despite rigorous chemotherapy treatment. Facing the daunting challenge of deciding the next steps, she wonders why there aren't more effective treatment options available. This poignant scenario echoes the broader

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later